XML 49 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2018
Schedule of Total Stock-Based Compensation Expense Included in Company's Consolidated Statements of Income and Comprehensive Income

The total stock-based compensation expense included in the Company’s consolidated statements of income and comprehensive income was as follows:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Cost of revenues

 

$

170

 

 

$

1,016

 

 

$

2,664

 

 

$

3,133

 

Research and development expense

 

 

708

 

 

 

712

 

 

 

2,249

 

 

 

2,284

 

Selling, general and administrative expense

 

 

4,335

 

 

 

3,117

 

 

 

17,092

 

 

 

14,417

 

Total pre-tax stock-based compensation expense

 

$

5,213

 

 

$

4,845

 

 

$

22,005

 

 

$

19,834

 

 

Summary of Activity for RSUs

The following table presents the activity for RSUs under the Plan:

 

 

 

Nine Months Ended September 30, 2018

 

 

 

Outstanding RSUs

 

 

Weighted Average

Grant Date

Fair Value

 

RSUs – beginning of period

 

 

943,379

 

 

$

47.57

 

Accrued dividend shares

 

 

46

 

 

$

105.26

 

Granted

 

 

260,341

 

 

$

112.49

 

Vested

 

 

(487,856

)

 

$

44.60

 

Forfeited

 

 

(62,021

)

 

$

65.37

 

RSUs – end of period

 

 

653,889

 

 

$

73.95

 

 

Stock Appreciation Rights (SARs) [Member]  
Summary of Activity for Outstanding and Exercisable Stock Appreciation Rights

The following table presents the activity for SARs under the Plan:

 

 

 

Nine Months Ended September 30, 2018

 

 

 

Outstanding SARs

 

 

Weighted Average

Grant Date

Fair Value

 

SARs – beginning of period

 

 

282,907

 

 

$

28.62

 

Exercised

 

 

(100,683

)

 

$

28.77

 

Forfeited or expired

 

 

(1,950

)

 

$

29.00

 

SARs Outstanding – end of period

 

 

180,274

 

 

$

28.52